Association between use of transdermal tulobuterol and short-term outcomes in patients with stroke and underlying chronic obstructive pulmonary disease: A retrospective cohort study

Transdermal tulobuterol, a long-acting beta agonist in a transdermal form, is available in some countries, including Japan, Korea, and China. It may provide an alternative treatment option for the management of chronic obstructive pulmonary disease (COPD) in patients who are unable to effectively us...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsuo, Yuichiro, Jo, Taisuke, Makito, Kanako, Matsui, Hiroki, Fushimi, Kiyohide, Yasunaga, Hideo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
6700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519481/
https://www.ncbi.nlm.nih.gov/pubmed/37746980
http://dx.doi.org/10.1097/MD.0000000000035032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519481/
https://www.ncbi.nlm.nih.gov/pubmed/37746980
http://dx.doi.org/10.1097/MD.0000000000035032

Ejemplares similares